Journal of Pediatric Psychology, Vol. 26, No. 1, 2001, pp. 1-9
© 2001 Society of Pediatric Psychology
Chemotherapeutic CNS Prophylaxis and Neuropsychologic Change in Children With Acute Lymphoblastic Leukemia: A Prospective Study
1 Southern Illinois University, 2 University of Arizona, 3 Clyde L. Choate Mental Health and Developmental Center, 4 University of California-San Francisco
All correspondence should be sent to Kimberly Andrews Espy, Department of Psychiatry, Mail Stop 6503, Southern Illinois University School of Medicine, Carbondale, Illinois 62901-6503. E-mail: kespy{at}siumed.edu .
Objective: To determine whether prophylactic CNS chemotherapy for childhood acute lymphoblastic leukemia is associated with declines in neuropsychological abilities.
Methods: Growth curve analysis was used to examine neuropsychological outcome and treatment-related change in children (N = 30) who were treated at two childhood cancer centers. A comprehensive test battery was administered at baseline (8 months), 2, 3, and 4 years postdiagnosis (age at diagnosis M = 5.90 years, SD = 4.2C).
Results: Results indicated modest declines in arithmetic, visual motor integration, and verbal fluency. Intrathecal and systemic treatment was related to poorer visual motor integration at 4 years postdiagnosis and a faster rate of decline in visual motor integration skills across the observation period than intrathecal treatment alone. Arithmetic proficiency at 4 years after diagnosis was related to maternal education, but the rate of decline was not. Verbal fluency was unrelated to demographic or treatment variables.
Conclusions: These findings suggest that neuropsychological outcome and declines are related to both demographic and treatment characteristics depending on the cognitive domain examined.
Key words: childhood cancer; CNS late effects; neuropsychology; growth curve analysis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. K. Campbell, M. Scaduto, D. Van Slyke, F. Niarhos, J. A. Whitlock, and B. E. Compas Executive Function, Coping, and Behavior in Survivors of Childhood Acute Lymphocytic Leukemia J. Pediatr. Psychol., July 30, 2008; (2008) jsn080v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gross-King, M. Booth-Jones, and M. Couluris Neurocognitive Impairment in Children Treated for Cancer: How Do We Measure Cognitive Outcomes? Journal of Pediatric Oncology Nursing, July 1, 2008; 25(4): 227 - 232. [Abstract] [PDF] |
||||
![]() |
M. Barrera, E. Atenafu, G. S. Andrews, and F. Saunders Factors Related to Changes in Cognitive, Educational and Visual Motor Integration in Children who Undergo Hematopoietic Stem Cell Transplant J. Pediatr. Psychol., June 1, 2008; 33(5): 536 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Moore, P. Miketova, M. Hockenberry, K. Krull, A. Pasvogel, M. Carey, and K. Kaemingk Methotrexate-Induced Alterations in Beta-Oxidation Correlate With Cognitive Abilities in Children With Acute Lymphoblastic Leukemia Biol Res Nurs, April 1, 2008; 9(4): 311 - 319. [Abstract] [PDF] |
||||
![]() |
M.E. Carey, M.W. Haut, S.L. Reminger, J.J. Hutter, R. Theilmann, and K.L. Kaemingk Reduced Frontal White Matter Volume in Long-Term Childhood Leukemia Survivors: A Voxel-Based Morphometry Study AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 792 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Reeves, S. Palmer, A. M. Gross, S. J. Simonian, L. Taylor, E. Willingham, and R. K. Mulhern Brief Report: Sluggish Cognitive Tempo among Pediatric Survivors of Acute Lymphoblastic Leukemia J. Pediatr. Psychol., October 12, 2007; (2007) jsm063v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Daly and R. T. Brown Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication J. Pediatr. Psychol., October 1, 2007; 32(9): 1111 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Nathan, S. K. Patel, K. Dilley, R. Goldsby, J. Harvey, C. Jacobsen, N. Kadan-Lottick, K. McKinley, A. K. Millham, I. Moore, et al. Guidelines for Identification of, Advocacy for, and Intervention in Neurocognitive Problems in Survivors of Childhood Cancer: A Report From the Children's Oncology Group Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 798 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Julvez, N. Ribas-Fito, M. Torrent, M. Forns, R. Garcia-Esteban, and J. Sunyer Maternal smoking habits and cognitive development of children at age 4 years in a population-based birth cohort Int. J. Epidemiol., August 1, 2007; 36(4): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Moore, C. J. Merkle, P. Miketova, R. K. Salyer, B. J. Torres, R. C. Schaeffer Jr, and D. W. Montgomery Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway. Biol Res Nurs, April 1, 2006; 7(4): 289 - 296. [Abstract] [PDF] |
||||
![]() |
N C Jansen, A Kingma, P Tellegen, R I van Dommelen, A Bouma, A Veerman, and W A Kamps Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research Arch. Dis. Child., March 1, 2005; 90(3): 301 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Montour-Proulx, S. M. Kuehn, D. L. Keene, N. J. Barrowman, E. Hsu, M.-A. Matzinger, H. Dunlap, and J. M. Halton Cognitive Changes in Children Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only According to the Pediatric Oncology Group 9605 Protocol J Child Neurol, February 1, 2005; 20(2): 129 - 133. [Abstract] [PDF] |
||||
![]() |
P. Miketova, K. Kaemingk, M. Hockenberry, A. Pasvogel, J. Hutter, K. Krull, and I. M. Moore Oxidative Changes in Cerebral Spinal Fluid Phosphatidylcholine during Treatment for Acute Lymphoblastic Leukemia Biol Res Nurs, January 1, 2005; 6(3): 187 - 195. [Abstract] [PDF] |
||||
![]() |
R. W. Butler and R. K. Mulhern Neurocognitive Interventions for Children and Adolescents Surviving Cancer J. Pediatr. Psychol., January 1, 2005; 30(1): 65 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Moore Advancing Biobehavioral Research in Childhood Cancer Journal of Pediatric Oncology Nursing, May 1, 2004; 21(3): 128 - 131. [Abstract] [PDF] |
||||







